Wave Life Sciences Ltd.
WVE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$97,008 | -$57,513 | -$161,823 | -$122,245 |
| Dep. & Amort. | $8,663 | $9,206 | $10,114 | $9,835 |
| Deferred Tax | $0 | $0 | $0 | -$12,644 |
| Stock-Based Comp. | $13,141 | $9,795 | $17,194 | $16,407 |
| Change in WC | -$75,822 | $19,081 | $6,722 | $7,010 |
| Other Non-Cash | $0 | $0 | $12 | $12,644 |
| Operating Cash Flow | -$151,026 | -$19,431 | -$127,781 | -$88,993 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$938 | -$1,115 | -$1,361 | -$560 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$75,044 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $75,044 | $0 |
| Other Inv. Act. | $0 | $0 | $106 | $0 |
| Investing Cash Flow | -$938 | -$1,115 | -$1,255 | -$560 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $236,176 | $131,277 | $52,325 | $54,970 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17,714 | $1,257 | $14,863 | $858 |
| Financing Cash Flow | $253,890 | $132,534 | $67,188 | $55,828 |
| Forex Effect | -$138 | -$95 | -$210 | -$208 |
| Net Chg. in Cash | $101,788 | $111,893 | -$62,058 | -$33,933 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $204,050 | $92,157 | $154,215 | $188,148 |
| End Cash | $305,838 | $204,050 | $92,157 | $154,215 |
| Free Cash Flow | -$151,964 | -$20,546 | -$129,142 | -$89,553 |